i failed to copy all of newrunner post but here is

i failed to copy all of newrunner post but here is the rest.imo


newrunner Sunday, 01/19/20 08:40:31 AM
Re: venus1



Venus1 you are so right! Nadar has a plan and it's not a buyout.....it will be about 32 partnerships.....

1. HIV cash and 50%

2. Breast Cancer Cash +50%

3. Colon Cancer cash + 50%


4. CytoDyn announced it will begin 8 pre-clinical studies on melanoma cancer, pancreatic, breast, prostate, colon, lung, liver, and stomach cancer.

$500.00 a share is not crazy!